Back to Search
Start Over
Randomized phase II adjuvant factorial study of dose-dense temozolomide alone and in combination with isotretinoin, celecoxib, and/or thalidomide for glioblastoma.
- Source :
- Neuro-Oncology; Feb2015, Vol. 17 Issue 2, p266-273, 8p, 1 Diagram, 1 Chart, 3 Graphs
- Publication Year :
- 2015
Details
- Language :
- English
- ISSN :
- 15228517
- Volume :
- 17
- Issue :
- 2
- Database :
- Complementary Index
- Journal :
- Neuro-Oncology
- Publication Type :
- Academic Journal
- Accession number :
- 108476765
- Full Text :
- https://doi.org/10.1093/neuonc/nou155